Profound Medical (NASDAQ: PROF; TSX: PRN) today announced that it has entered into a consulting agreement with Leonard Wheeler—former NFL player, entrepreneur, author, corporate consultant, co-executive director of the NFL Legends Community, and national podcaster.
Profound noted this partnership marks a significant new chapter for the company. As a global brand ambassador, Mr. Wheeler will help establish both in-person and digital platforms designed to educate, connect, and empower men—driving worldwide awareness Profound’s TULSA-PRO system.
Mr. Wheeler, who recently underwent the TULSA procedure for organ-confined prostate cancer, shared, “Once I understood the difference, it was an easy decision. The TULSA procedure not only treated my cancer effectively, but it also protected the quality of life I value. I feel incredibly blessed by the results and deeply motivated to help other men become aware of this option.”
“This is bigger than me. It’s about helping men and their families see a different way forward. Because once you know your options, you can take control of your health and your future,” he added.
In a statement, Tom Tamberrino, CCO of Profound, said, “Our deliverables for 2025 are to drive awareness and adoption of, access to, and advocacy for TULSA-PRO at the physician, patient, and private payer levels. To that end, we are excited to partner with Leonard and look forward to working with him to soon launch an immersive TULSA-PRO awareness campaign on multiple fronts, including digital media, social media, podcasting, and more.”
TULSA employs real-time MR guidance for precision to preserve patients’ urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57°C. TULSA is an incision- and radiation-free “one-and-done” procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with TULSA. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report a quick recovery to their normal routine.
